IDH is a Common and Debilitating Problem in Dialysis

IDH occurs during 25% to 50% of end-stage renal disease (ESRD) hemodialysis treatments¹

• IDH is multifactorial, but cardiovascular dysfunction is a common cause of IDH²

Carnitor^® Injection Corrects DCD, Which Can Reduce Hypotensive Episodes

References: 1. Schreiber M: Clinical dilemmas in dialysis: managing the hypotensive patient setting the stage. Am J Kidney Dis 2001;38:S1-S10. 2. Eknoyan G, et al: Practice recommendations for the use of L-carnitine in dialysis-related carnitine disorder: National Kidney Foundation: Carnitine Consensus Conference. Am J Kidney Dis 2003;41:868-876. 3. Sunder-Plassmann G, Horl W: Effect of erythropoietin on cardiovascular diseases. Am J Kidney Dis 2001;38:S20-S25. 4. Ahmad S, et al: Multicenter trial of L-carnitine in maintenance hemodialysis patients. II. Clinical and biochemical effects. Kidney Int 1990;38:912-918.